Mesalamine Associated Bradycardia
- PMID: 29872605
- PMCID: PMC5985920
- DOI: 10.7759/cureus.2425
Mesalamine Associated Bradycardia
Abstract
A 38-year-old female presented with an acute flare of ulcerative colitis. She was started on prednisone and mesalamine. Within 24 hours of initiating mesalamine, she developed sinus bradycardia. After holding mesalamine, the heart rate returned to normal within five days. Our case illustrates the third described case, to our knowledge, of severe sinus bradycardia secondary to mesalamine.
Keywords: bradycardia; drug side effects; ulcerative colitis.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Baron JH, Connell AM, Lennard-Jones JE, Jones FA. Lancet. 1962;1:1094–1096. - PubMed
-
- Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Miner P Jr, Hanauer S, Robinson M, Schwartz J, Arora S. Dig Dis Sci. 1995;40:296–304. - PubMed
-
- Severe symptomatic sinus bradycardia associated with mesalamine use. Asirvatham S, Sebastian C, Thadani U. Am J Gastroenterol. 1998;93:470–471. - PubMed
-
- An experiment to determine the active therapeutic moiety of sulphasalazine. Azad Khan AK, Piris J, Truelove SC. Lancet. 1977;310:892–895. - PubMed
-
- Lichtenstein GR, Blonski W, Mudireddy PRS. New York: Springer; 2014. Atsushi: Medical Therapy of Ulcerative Colitis.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources